[Reuters] – U.S. drugmaker Eli Lilly and Co on Tuesday forecast a decline in earnings this year in line with Wall Street estimates, with results hurt by cheaper generic forms of its Zyprexa . . . → Read More: Eli Lilly and Company (NYSE:LLY) – Lilly issues 2014 forecast in line with Wall St estimates
[Reuters] – U.S. drugmaker Eli Lilly and Co on Tuesday forecast a decline in earnings this year in line with Wall Street estimates, with results hurt by cheaper generic forms of its Zyprexa schizophrenia drug and …
Read more on this.
Eli Lilly and Company (LLY), with a … [visit site to read more]
